BioSpace News Archive

Business

Kala Pharmaceuticals Reports Second Quarter 2018 Financial Results

PDUFA Target Action Date for INVELTYS™ is August 24, 2018

August 9, 2018
·
11 min read
Business

PAVmed Inc. to Hold SECOND QUARTER FINANCIAL RESULTS AND BUSINESS UPDATE Conference Call on August 22, 2018

PAVmed Inc. announced that the Company will report second quarter financial results on or before August 14, 2018 and host a conference call on Wednesday, August 22, 2018 at 4:30 p.m. Eastern time.

August 9, 2018
·
2 min read
Policy

Neptune Files Two Patent Applications for Innovative Cannabis Extraction Processes

Neptune Technologies & Bioressources Inc. has filed two applications with the United States Patent and Trademark Office (USPTO) for patents related to the extraction of cannabis material.

August 9, 2018
·
4 min read
Business

Precipio Appoints New Board Member to Replace Departing Director

Kathy LaPorte brings 30-year track record of VC success financing and operating innovative biopharma, diagnostics and healthcare companies

August 9, 2018
·
3 min read
Business

Agenus Reports Second Quarter 2018 Financial Results and Provides Corporate Update

Cash milestones earned from Merck & Incyte

August 9, 2018
·
8 min read
Drug Development

Audentes Therapeutics to Present at the 2018 Wedbush PacGrow Healthcare Conference

Audentes Therapeutics, Inc. today announced that Natalie Holles, President and Chief Operating Officer, will present at the 2018 Wedbush PacGrow Healthcare Conference in New York.

August 9, 2018
·
1 min read
Biotech Beach

Biocept Announces $11.6 Million in Expected Gross Proceeds from Recently Expired Rights Offering

The Company accepted all valid subscriptions that were presented and estimates that the Rights Offering will result in approximately $11.6 million in gross proceeds.

August 9, 2018
·
4 min read
Business

BioSpecifics Technologies Corp. Reports Second Quarter 2018 Financial Results

Phase 1 trial of CCH for treatment of Uterine fibroids now fully enrolled

August 9, 2018
·
20 min read
Genetown

Synspira’s PAAG Therapy Demonstrates Persistence Against Pseudomonas aeruginosa Persister Cells

Results published in Frontiers in Microbiology-Antimicrobials, Resistance and Chemotherapy

August 9, 2018
·
5 min read
Deals

Ligand Makes Offer to Acquire Vernalis, a Leader in Structure-Based Drug Discovery, For Approximately $43 Million in Cash

Ligand to gain broad portfolio of partnered and unpartnered programs, a self-funding R&D group and approximately $32 million of net cash

August 9, 2018
·
8 min read